Drug intelligence / Profile preview

iso-mukaadial acetate

Development stage
Preclinical
Lead developer
Durban University of Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Iso-mukaadial acetate is a drimane-type sesquiterpenoid natural product isolated from the ground stem bark of *Warburgia salutaris*. It has been investigated for its potential therapeutic applications in oncology, diabetes, and malaria. In cancer research, the compound has demonstrated cytotoxic activity and the induction of apoptosis in breast, pancreatic, and colon cancer models, although in vivo studies have noted potential toxicity and solubility challenges. In diabetes research, it has been shown to enhance glucose uptake in skeletal muscle cells, activate the AMPK and AKT pathways, and inhibit carbohydrate digestive enzymes. In malaria research, it has been shown to directly bind and inhibit *Plasmodium falciparum* hypoxanthine-guanine-xanthine phosphoribosyltransferase (PfHGXPRT) and disrupt the chaperone function of *Plasmodium falciparum* heat shock protein 90 (PfHsp90).

Other names
IMAIso-mukaadial acetate
02

Targets

Sucrase-IsomaltaseAMY (Pancreatic alpha-amylase)HPRT1 (Hypoxanthine-guanine phosphoribosyltransferase)HSP90AA1 (Heat shock protein HSP90-alpha)

Beyond the preview

Go deeper on iso-mukaadial acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iso-mukaadial acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call